Abstract
Background
Women with irritable bowel syndrome (IBS) report sexual dysfunction. Comprehensive self-management (CSM) intervention has been shown to reduce gastrointestinal, psychological, and somatic symptoms in IBS women. Whether this intervention also reduces sexual dysfunction is not known.
Aims
We sought to compare demographic and clinical factors in IBS women with and without sexual dysfunction as defined by the Arizona sexual experiences scale (ASEX) and to test the effects of CSM treatment on sexual dysfunction scores and on the sexual relations subscale of an IBS quality of life (IBSQOL) scale which measures the effect of IBS on sexual QOL.
Methods
IBS (Rome II) women enrolled in a randomized clinical trial of CSM treatment were characterized as having sexual dysfunction (N = 89) or not (N = 86) at baseline based on ASEX criteria. Baseline characteristics and symptoms were compared between the two groups. Post-intervention changes were compared between the CSM and the usual care arms of the randomized trial.
Results
Women meeting ASEX criteria for sexual dysfunction were older, had higher lifetime depression and antidepressant use, more primary care/MD visits, fewer mental healthcare visits, and greater sleep disturbance than those without sexual dysfunction. No significant group differences in gastrointestinal or somatic symptoms were observed. Compared with usual care treatment, CSM increased sexual QOL scores and had a weaker effect on ASEX scores.
Conclusions
Severity of IBS symptoms at baseline did not differ between IBS women with or without sexual dysfunction. The CSM intervention can reduce the effect of IBS on sexual QOL.
Similar content being viewed by others
Abbreviations
- ASEX:
-
Arizona Sexual Experiences Scale
- CSM:
-
Comprehensive self-management
- IBS:
-
Irritable bowel syndrome
- NSexD:
-
No sexual dysfunction group
- QOL:
-
Quality of life
- SexD:
-
Sexual dysfunction group
- SSRI:
-
Selective serotonin reuptake inhibitors
References
Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in north america. Am J Gastroenterol. 2002;97:S7–S26.
Fass R, Fullerton S, Naliboff B, Hirsh T, Mayer EA. Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion. 1998;59:79–85.
Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in united states women: Prevalence and correlates. Obstet Gynecol. 2008;112:970–978.
West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of us women. Arch Intern Med. 2008;168:1441–1449.
Loeb TB, Williams JK, Carmona JV, et al. Child sexual abuse: Associations with the sexual functioning of adolescents and adults. Annu Rev Sex Res. 2002;13:307–345.
Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril. 2001;76:456–460.
Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: A 9-year prospective population-based study. The melbourne women’s midlife health project. Climacteric. 2004;7:375–389.
Al-Azzawi F, Bitzer J, Brandenburg U, et al. Therapeutic options for postmenopausal female sexual dysfunction. Climacteric. 2010;13:103–120.
Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998;13:S1–S4.
Rellini AH, Meston CM. Sexual self-schemas, sexual dysfunction, and the sexual responses of women with a history of childhood sexual abuse. Arch Sex Behav. 2011;40:351–362.
Heitkemper M, Jarrett M, Taylor P, Walker E, Landenburger K, Bond EF. Effect of sexual and physical abuse on symptom experiences in women with irritable bowel syndrome. Nurs Res. 2001;50:15–23.
Drossman DA, Camilleri M, Mayer EA, Whitehead WE. Aga technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108–2131.
Cain KC, Jarrett ME, Burr RL, Rosen S, Hertig VL, Heitkemper MM. Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome. Dig Dis Sci. 2009;54:1542–1549.
Shifren JL, Johannes CB, Monz BU, Russo PA, Bennett L, Rosen R. Help-seeking behavior of women with self-reported distressing sexual problems. J Womens Health (Larchmt). 2009;18:461–468.
Evangelia N, Kirana PS, Chiu G, Link C, Rosen R, Hatzichristou D. Level of bother and treatment-seeking predictors among male and female in-patients with sexual problems: A hospital-based study. J Sex Med. 2010;7:700–711.
McGahuey CA, Gelenberg AJ, Laukes CA, et al. The arizona sexual experience scale (asex): Reliability and validity. J Sex Marital Ther. 2000;26:25–40.
Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Prevalence and impact of antidepressant-associated sexual dysfunction in three european countries: Replication in a cross-sectional patient survey. J Psychopharmacol. 2010;24:489–496.
Lew-Starowicz M, Gellert R. The sexuality and quality of life of hemodialyzed patients–ased multicenter study. J Sex Med. 2009;6:1062–1071.
Soykan A, Boztas H, Idilman R, et al. Sexual dysfunctions in hcv patients and its correlations with psychological and biological variables. Int J Impot Res. 2005;17:175–179.
Gelenberg AJ, McGahuey C, Laukes C, et al. Mirtazapine substitution in ssri-induced sexual dysfunction. J Clin Psychiatry. 2000;61:356–360.
Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654–660.
Aboumarzouk OM, Agarwal T, Antakia R, Shariff U, Nelson RL: Cisapride for intestinal constipation. Cochrane Database Syst Rev. 2011:CD007780.
Schey R, Rao SS. Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome. Dig Dis Sci. 2011;56:1619–1625.
Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22–32.
Jarrett ME, Cain KC, Burr RL, Hertig VL, Rosen SN, Heitkemper MM. Comprehensive self-management for irritable bowel syndrome: Randomized trial of in-person vs. Combined in-person and telephone sessions. Am J Gastroenterol. 2009;104:3004–3014.
Drossman D, Corazziari E, Talley N, Thompson W, Whitehead WE. Rome ii: the functional gastrointestinal disorders. McLean: Degnon Associates, Inc.; 2000.
Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther. 1997;11:547–552.
Derogatis L. Brief symptom inventory: Administration, scoring and procedures manual. 4th ed. Minneapolis: National Computer Systems; 1993.
Bernstein DP. Childhood trauma questionnaire. San Antonio: The Psychological Corporation; 1998.
Bernstein DP, Ahluvalia T, Pogge D, Handelsman L. Validity of the childhood trauma questionnaire in an adolescent psychiatric population. J Am Acad Child Adolesc Psychiatry. 1997;36:340–348.
Buysse DJ, Reynolds CF 3rd. Monk TH, Berman SR, Kupfer DJ: The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
Guthrie E, Creed FH, Whorwell PJ. Severe sexual dysfunction in women with the irritable bowel syndrome: Comparison with inflammatory bowel disease and duodenal ulceration. Br Med J (Clin Res Ed). 1987;295:577–578.
APA, ed. Diagnostic and statistical manual of mental disorders, text revision. 4th ed. Washington, DC: American Psychiatric Association; 2000.
Choung RS, Herrick LM, Locke GR III, Zinsmeister AR, Talley NJ. Irritable bowel syndrome and chronic pelvic pain: A population-based study. J Clin Gastroenterol. 2010;44:696–701.
Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther. 1997;11:553–559.
van den Brink M, Bandell-Hoekstra EN, Abu-Saad HH. The occurrence of recall bias in pediatric headache: A comparison of questionnaire and diary data. Headache. 2001;41:11–20.
Lewandowski AS, Palermo TM, Kirchner HL, Drotar D. Comparing diary and retrospective reports of pain and activity restriction in children and adolescents with chronic pain conditions. The Clinical Journal of Pain. 2009;25:299–306.
Niere K, Jerak A. Measurement of headache frequency, intensity and duration: Comparison of patient report by questionnaire and headache diary. Physiother Res Int. 2004;9:149–156.
Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish working group for the study of psychotropic-related sexual dysfunction. J Clin Psychiatry. 2001;62:10–21.
Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol. 2009;29:157–164.
Yang JC, Park K, Eun SJ, et al. Assessment of cerebrocortical areas associated with sexual arousal in depressive women using functional mr imaging. J Sex Med. 2008;5:602–609.
Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: Systematic review and meta-analysis. Gut. 2009;58:367–378.
Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 2000;61:276–281.
Ashton AK, Mahmood A, Iqbal F. Improvements in ssri/snri-induced sexual dysfunction by switching to escitalopram. J Sex Marital Ther. 2005;31:257–262.
Ozmenler NK, Karlidere T, Bozkurt A, et al. Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Hum Psychopharmacol. 2008;23:321–326.
Safarinejad MR. Reversal of ssri-induced female sexual dysfunction by adjunctive bupropion in menstruating women: A double-blind, placebo-controlled and randomized study. J Psychopharmacol. 2011;25:370–378.
Bachmann G, Bobula J, Mirkin S. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy. Climacteric. 2010;13:132–140.
Schwartz TL, Nasra GS, Ashton AK, et al. An open-label study to evaluate switching from an ssri or snri to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder. Ann Clin Psychiatry. 2007;19:25–30.
Acknowledgments
Supported by grants NINR, NIH (RO1 NR004142 and P30 NR04001).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eugenio, M.D., Jun, SE., Cain, K.C. et al. Comprehensive Self-Management Reduces the Negative Impact of Irritable Bowel Syndrome Symptoms on Sexual Functioning. Dig Dis Sci 57, 1636–1646 (2012). https://doi.org/10.1007/s10620-012-2047-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-012-2047-1